Author: Bella Hayes

New York, New York–(Newsfile Corp. – December 27, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zeta Global (NYSE:) Holdings Corp. (NYSE: ZETA) between February 27, 2024 and November 13, 2024, both dates inclusive (the “Class Period”), of the important January 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Zeta securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Zeta class action, go to https://rosenlegal.com/submit-form/?case_id=31333…

Read More

New York, New York–(Newsfile Corp. – December 27, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS”) of Rentokil Initial plc (NYSE: LON:) between December 1, 2023 and September 10, 2024, both dates inclusive (the “Class Period”), of the important January 27, 2025 lead plaintiff deadline. SO WHAT: If you purchased Rentokil ADSs during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Rentokil class action, go to…

Read More

New York, New York–(Newsfile Corp. – December 27, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Match Group, Inc. (NASDAQ: NASDAQ:) between May 2, 2023 and November 6, 2024, both dates inclusive (the “Class Period”), of the important January 24, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Match Group securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To…

Read More

New York, New York–(Newsfile Corp. – December 27, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Kaspi.kz securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To…

Read More

New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Warner Bros. Discovery, Inc. (NASDAQ: NASDAQ:) between February 23, 2024 and August 7, 2024, both dates inclusive (the “Class Period”), of the important January 24, 2025 lead plaintiff deadline. SO WHAT: If you purchased WBD securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the WBD class action, go to https://rosenlegal.com/submit-form/?case_id=31683 or…

Read More

New York, New York–(Newsfile Corp. – December 27, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) pursuant and/or traceable to the Kyverna’s initial public offering conducted on February 8, 2024 (the “IPO”), of the important February 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased Kyverna common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Kyverna class action, go to https://rosenlegal.com/submit-form/?case_id=32239 or call…

Read More

New York, New York–(Newsfile Corp. – December 27, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aehr Test Systems (NASDAQ: AEHR) between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased Aehr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Aehr class action, go to https://rosenlegal.com/submit-form/?case_id=31986 or call…

Read More

SHANGHAI (Reuters) – China will reduce import tariffs on ethane and certain recycled and aluminium raw materials from next year, the government said on Saturday. The Ministry of Finance announced adjustments to various import tariff categories, effective Jan. 1, aimed at increasing imports of high-quality products, expanding domestic demand and promoting high-level opening-up, it said in a statement. Provisional import tariffs below the most-favoured-nation rates will be applied to 935 items, the ministry said. Import tariffs will be reduced on ethane and certain recycled copper and aluminium raw materials to advance green and low-carbon development. Tariffs will rise on commodities…

Read More

Patrick W. Smith, a significant shareholder of Oncocyte Corp (NASDAQ:OCX), recently increased his stake in the company with a substantial purchase of common stock. According to a recent filing, Smith acquired 90,219 shares at a price of $2.13 per share, totaling approximately $192,166. The timing is notable as InvestingPro data shows the stock trading near its 52-week low of $1.97, with analyst price targets ranging from $4.00 to $4.25. This transaction boosts his total holdings to 1,773,903 shares. The shares are held indirectly through the Smith Irrevocable Trust, of which Smith is the trustee. With the stock’s RSI indicating oversold…

Read More

Philadelphia, Pennsylvania–(Newsfile Corp. – December 27, 2024) – Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) on behalf of purchasers of ASP Isotopes securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”). Investors that suffered losses from ASP ISOTOPES (NASDAQ: ASPI) investments can follow the link below for more information regarding the lawsuit:CLICK HERE to learn more about the lawsuit. Investors who purchased or acquired ASP ISOTOPES securities during the Class Period may, no later than FEBRUARY 3, 2025,…

Read More